📧 Communication
websiteCommunication Details
From
Not specified
Linked to Not specified
To
FDA
FDA
Subject
MedWatch Program
Message Content
www.fda.gov/medwatch
📄 Source Document
HOUSE_OVERSIGHT_026366.jpg
ESTATE Collection
Document Summary
This document is a corporate communication and product information sheet for the prescription drug Praluent (alirocumab), manufactured by Sanofi. It details the ODYSSEY clinical trial program, provides important safety information for patients, and includes a legal disclaimer. The document is marked with the identifier 'HOUSE_OVERSIGHT_026366' but contains no information whatsoever related to Jeffrey Epstein, his associates, finances, or travel.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein communication